Persistence and immune memory to hepatitis B vaccine 20 y after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 7, 2012, Pages 896-904

  Poovorawan, Yong ^a   Chongsrisawat, Voranush ^a   Theamboonlers, Apiradee ^a   Leroux Roels, Geert ^b   Crasta, Priya Diana ^c   Hardt, Karin ^c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Anamnestic response; Efficacy; Hepatitis B; Persistence; Thailand; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG RECHALLENGE; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; GEOMETRY; HUMAN; HUMAN EXPERIMENT; IMMUNOLOGICAL MEMORY; MALE; NORMAL HUMAN; THAILAND; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; MALE; THAILAND; VACCINATION; YOUNG ADULT;

EID: 84864069577     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.19989     Document Type: Article

References (29)

1. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2009; 84:405-19; PMID: 19817017
2. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26:6266-73; PMID: 18848855; http://dx.doi.org/10.1016/j.vaccine.2008.09.056
3. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34:1329-39; PMID:16249217; http://dx.doi.org/10. 1093/ije/dyi206
4. Poovorawan Y, Chongsrisawat V, Tangkijvanich P. Problems and prevention of viral hepatitis in Thailand. J Med Assoc Thai 2001; 84(Suppl 1):S18-25; PMID: 11529332
5. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15:1356-61; PMID:11197043; http://dx.doi.org/10.1046/j.1440-1746. 2000.0150121356.x
6. Lolekha S, Warachit B, Hirunyachote A, Bowonkiratikachorn P, West DJ, Poerschke G. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine 2002; 20:3739-43; PMID: 12399203; http://dx.doi.org/10.1016/S0264-410X(02)00358-4
7. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010; 28:730-6; PMID:19892043; http://dx.doi.org/10.1016/j.vaccine.2009.10.074
8. World Health Organization. WHO expanded programme on immunization. Global advisory group. Wkly Epidemiol Rec 1992; 3:11-6.
9. Heron L, Selnikova O, Moiseieva A, Van Damme P, van der Wielen M, Levie K, et al. Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial. Vaccine 2007; 25:2817-22; PMID:17276552; http://dx.doi.org/10.1016/j.vaccine.2006.12.021
10. Centers for Disease Control and Prevention (CDC). Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:868-70; PMID:12970620
11. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006; 11:1496-502; PMID: 17002723; http://dx.doi.org/10.1111/j.1365-3156.2006.01709.x
12. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 2011; 18:369-75; PMID:20384962; http://dx.doi.org/10.1111/j.1365-2893.2010.01312.x
13. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54:1-31; PMID:15647722
14. McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200:1390-6; PMID:19785526; http://dx.doi.org/10.1086/606119
15. Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006; 28:126-35; PMID:16782778; http://dx.doi.org/10.1093/epirev/ mxj010
16. Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 2005; 194:163-8; PMID:15834754; http://dx.doi.org/10.1007/s00430-004-0231-4
17. Poovorawan Y, Sanpavat S, Pongpunglert W, Chumdermpadetsuk S, Sentrakul P, Vandepapelière P, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 1992; 11:816-21; PMID:1408478; http://dx.doi.org/10.1097/00006454-199210000- 00002
18. Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed 1997; 77:F47-51; PMID: 9279183; http://dx.doi.org/10.1136/fn.77.1.F47
19. Banatvala JE, Van Damme P. Hepatitis B vaccine - do we need boosters? J Viral Hepat 2003; 10:1-6; PMID: 12558904; http://dx.doi.org/10.1046/j.1365-2893. 2003.00400.x
20. Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 2008; 27:881-5; PMID:18756185; http://dx.doi.org/10.1097/INF.0b013e31817702ba
21. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958-64; PMID:17714836; http://dx.doi.org/10.1016/j.vaccine.2007.06.059
22. Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 2007; 120:e373-81; PMID:17636112; http://dx.doi.org/10.1542/peds.2007-0131
23. Chinchai T, Chirathaworn C, Praianantathavorn K, Theamboonlers A, Hutagalung Y, Bock PH, et al. Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol 2009; 22:125-30; PMID:19326999; http://dx.doi.org/ 10.1089/vim.2008.0087
24. Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine 1995; 13:443-7; PMID:7639012; http://dx.doi.org/10.1016/0264-410X(94)00010-K
25. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KGS, Dörner T, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006; 6:741-50; PMID: 16977339; http://dx.doi.org/10.1038/nri1886
26. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53:68-75; PMID:21653306; http://dx.doi.org/10.1093/cid/ cir270
27. Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40:1415-20; PMID:15565627; http://dx.doi.org/10.1002/hep.20490
28. Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184:905-8; PMID:11509998; http://dx.doi.org/10.1086/323396
29. Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-nguanmoo P, Poovorawan Y. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine 2009; 27:6110-5; PMID:19716459; http://dx.doi.org/10.1016/j.vaccine.2009.08.034